Tag: Cardiovascular diseases

May 8, 2026

Multinational Validation of PREVENT and SCORE2 Cardiovascular Risk Scores

Semaglutide Reduces Cardiovascular Events by 20% in High-Risk Patients | SELECT Trial

April 2, 2026

Semaglutide Reduces Cardiovascular Events by 20% in High-Risk Patients | SELECT Trial

Wine vs. Spirits: Alcohol Type Impacts Health Risk, Study Finds

March 21, 2026

Wine vs. Spirits: Alcohol Type Impacts Health Risk, Study Finds

Web Analytics Made Easy - Statcounter